Literature DB >> 20211940

Increased susceptibility of Nrf2-null mice to 1-bromopropane-induced hepatotoxicity.

Fang Liu1, Sahoko Ichihara, William M Valentine, Ken Itoh, Masayuki Yamamoto, Sahabudeen Sheik Mohideen, Junzoh Kitoh, Gaku Ichihara.   

Abstract

1-Bromopropane (1-BP) was introduced as an alternative to ozone-depleting solvents. However, it was found to exhibit neurotoxicity, reproductive toxicity, and hepatotoxicity in rodents and neurotoxicity in human. However, the mechanisms underlying the toxicities of 1-BP remain elusive. The present study investigated the role of oxidative stress in 1-BP-induced hepatotoxicity using nuclear factor erythroid 2-related factor 2 (Nrf2)-null mice. Groups of 24 male Nrf2-null mice and 24 male wild-type (WT) C57BL/6J mice were each divided into three groups of eight and exposed to 1-BP at 0, 100, or 300 ppm for 8 h/day for 28 days by inhalation. Liver histopathology showed significantly larger area of necrosis in Nrf2-null mice relative to WT mice at the same exposure level. Nrf2-null mice also had greater malondialdehyde (MDA) levels, higher ratio of oxidized glutathione/reduced form of glutathione, and lower total glutathione content. The constitutive level and the increase in ratio per exposure level of glutathione S-transferase (GST) activity were lower in the liver of Nrf2-null mice than WT mice. Exposure to 1-BP at 300 ppm increased the messenger RNA levels of heme oxygenase-1 (HO-1), glutamate-cysteine ligase modifier subunit (GcLm), glutamate-cysteine synthetase (GcLc), glutathione reductase, and NAD(P)H: quinone oxidoreductase 1 (NQO1) in WT mice but not in Nrf2-null mice except for GST Yc2. Nrf2-null mice were more susceptible to 1-BP-induced hepatotoxicity. That oxidative stress plays a role in 1-BP hepatotoxicity is deduced from the low expression levels and activities of antioxidant enzymes and high MDA levels in Nrf2-null mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211940     DOI: 10.1093/toxsci/kfq075

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  14 in total

Review 1.  Nrf2: a potential target for new therapeutics in liver disease.

Authors:  A M Bataille; J E Manautou
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

2.  Altered behavioral development in Nrf2 knockout mice following early postnatal exposure to valproic acid.

Authors:  Melody A Furnari; Constance Lay-Lay Saw; Ah-Ng Kong; George C Wagner
Journal:  Brain Res Bull       Date:  2014-10-20       Impact factor: 4.077

3.  Tissue specific dysregulated protein subnetworks in type 2 diabetic bladder urothelium and detrusor muscle.

Authors:  Sara E Tomechko; Guiming Liu; Mingfang Tao; Daniela Schlatzer; C Thomas Powell; Sanjay Gupta; Mark R Chance; Firouz Daneshgari
Journal:  Mol Cell Proteomics       Date:  2015-01-08       Impact factor: 5.911

4.  Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury.

Authors:  Robert A Roth; Omar Kana; David Filipovic; Patricia E Ganey
Journal:  Expert Opin Drug Metab Toxicol       Date:  2022-08-24       Impact factor: 4.936

Review 5.  A review of the evidence that ochratoxin A is an Nrf2 inhibitor: implications for nephrotoxicity and renal carcinogenicity.

Authors:  Alice Limonciel; Paul Jennings
Journal:  Toxins (Basel)       Date:  2014-01-20       Impact factor: 4.546

6.  Ozone-induced changes in oxidative stress parameters in brain regions of adult, middle-age, and senescent Brown Norway rats.

Authors:  Prasada Rao S Kodavanti; Matthew Valdez; Judy E Richards; Datonye I Agina-Obu; Pamela M Phillips; Kimberly A Jarema; Urmila P Kodavanti
Journal:  Toxicol Appl Pharmacol       Date:  2020-11-27       Impact factor: 4.219

7.  Nrf2 Activation Attenuates Acrylamide-Induced Neuropathy in Mice.

Authors:  Chand Basha Davuljigari; Frederick Adams Ekuban; Cai Zong; Alzahraa A M Fergany; Kota Morikawa; Gaku Ichihara
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

Review 8.  Role of the Nrf2-ARE pathway in liver diseases.

Authors:  Sang Mi Shin; Ji Hye Yang; Sung Hwan Ki
Journal:  Oxid Med Cell Longev       Date:  2013-05-09       Impact factor: 6.543

9.  Nrf2 protection against liver injury produced by various hepatotoxicants.

Authors:  Jie Liu; Kai Connie Wu; Yuan-Fu Lu; Edugie Ekuase; Curtis D Klaassen
Journal:  Oxid Med Cell Longev       Date:  2013-05-23       Impact factor: 6.543

10.  Curcumin attenuates chronic ethanol-induced liver injury by inhibition of oxidative stress via mitogen-activated protein kinase/nuclear factor E2-related factor 2 pathway in mice.

Authors:  Zhang E Xiong; Wei Guo Dong; Bao Ying Wang; Qiao Yun Tong; Zhong Yan Li
Journal:  Pharmacogn Mag       Date:  2015 Oct-Dec       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.